Breast Cancer Doctors Worldwide

Specializes in non-surgical treatments for breast conditions, including large cysts and precancerous diseases. Uses integrative approaches like mistletoe therapy and high-dose vitamin C.

• Oncologist-mammologist with expertise in hormonal treatments for breast cancer
• Skilled in biopsy techniques for breast skin pathologies
• Participant in international conferences with German and Turkish doctors
• Focuses on natural pain relief and life extension for cancer patients

The doctor is a specialist in General Surgery and Surgical Oncology with over 28 years of clinical experience. A graduate of the Medical University of Łódź, the doctor earned a PhD in Medical Sciences in 2003 and completed a postgraduate program in Oncological, Reconstructive, and Aesthetic Breast Surgery at the Autonomous University of Barcelona.

The doctor focuses on the comprehensive surgical management of breast cancer, utilizing advanced reconstructive techniques to restore symmetry and function. Expertise includes breast reconstruction, reduction, reshaping, and augmentation. The doctor has refined these skills through international fellowships at institutions such as the European Institute of Oncology in Milan and Institut Gustave Roussy in Paris.

Over 5,000 breast cancer surgeries performed – Dr. Gentilini leads the Breast Unit at San Raffaele Hospital, specializing in breast-conserving techniques.

• Head of the SOUND study – pioneering less invasive axillary surgery
• Focuses on young women and pregnant patients with breast cancer
• Author of 100+ papers on breast tumor treatment
• Vice President of EU-BREAST organization
• Fellowship-trained at NewYork–Presbyterian Hospital

Dr. Enrique Grande is a renowned medical oncologist at Hospital Ruber Internacional in Madrid. He has authored over 300 peer-reviewed scientific publications. Dr. Grande focuses on genitourinary and rare endocrine tumors. He serves as a pioneer in precision oncology and molecular profiling.

• Directs the Medical Oncology Department at QuirónSalud.
• Treats complex cases of bladder, kidney, and prostate cancers.
• Contributes to international guidelines for ESMO and ASCO.
• Leads global clinical trials to set new cancer care standards.

Dr. He Weibing is a pioneer of argon-helium cryoablation in China with more than 20 years of frontline practice. He was a founding member of Fuda Cancer Hospital (Guangzhou). He co-founded its Minimally Invasive Tumor Treatment Center and served as Executive Deputy Director. He also helped found the Ablation Group of the China Anti-Cancer Association. He has been the primary operator in more than 10,000 procedures.

He specializes in tumor cryoablation and is proficient in 125I seed brachytherapy, with a focus on liver and lung cancers. He proposed ten argon-helium techniques. Key co-authored data include: lung cryotherapy n=508; NSCLC n=120 (CR 25.5%, PR 41.8%, 6/12/24-month survival 64%/55%/36%); pancreatic cancer n=38 (median survival 12 months). He served on editorial boards in 2008 and 2010. He has been a national trainer for Varian and Boston Scientific since 2001.

Dr. Ayshe Okumush is a radiation oncologist at Private NeoLife Medical Center. She earned her MD from Karadeniz Technical University in 2003. She completed a residency in radiation oncology at Sisli Etfal Training and Research Hospital from 2006 to 2011.

She served as a specialist at Diyarbakir Uckuyular Training and Research Hospital from 2011 to 2013 and at Sisli Etfal from 2013 to 2016. She then worked at Yeni Yuzyil University Private Gaziosmanpasa Hospital from 2016 to 2026. She joined NeoLife in 2026.

Memberships: Turkish Society for Radiation Oncology (TROD) and the European Society for Radiotherapy and Oncology (ESTRO). Clinical focus: SRS, SRT, SBRT; VMAT, IMRT; radiotherapy for head and neck, lung, and brain tumors; SGRT, TBI, and 3D brachytherapy.

Professor Luo Xiaoping is a nationally recognized interventional radiologist and a leading authority in Western China. He began pioneering vascular interventions in the early 1990s. He helped found the Interventional Group at the Second Affiliated Hospital of Chongqing Medical University.

He has completed over 100,000 interventional procedures, including about 4,000 complex cases. His key skills include TACE for hepatocellular carcinoma, Budd–Chiari interventions, TIPS, and single-stage bilateral stenting for hilar biliary obstruction, with success rates near 100%. He has been a master’s supervisor since 2007. He has trained many physicians, guided complex cases at more than 40 major hospitals across Western China, and helped build interventional programs. He has published 32 papers as first or corresponding author (22 CSCD core, 4 Chinese core, 6 CSCD extended).

Prof. Sezer Sağlam brings over 27 years of expertise in medical oncology, focusing on breast cancer at Gayrettepe Florence Nightingale Hospital.

• Professor of Medical Oncology since 2016
• Specializes in gastrointestinal oncology – a key factor in complex breast cancer cases
• Member of leading oncology societies including ESMO and ASCO
• Trained at Istanbul University – one of Turkey's top medical schools

Dr. Dov Zippel is a surgical oncologist and head of the Meirav Breast Center. Forbes Israel named him to its Best Doctors list in 2025. He treats benign and malignant breast tumors and melanoma at Sheba Medical Center. Dr. Zippel completed a surgical oncology fellowship at the University of Calgary in Canada.

• Performs breast-conserving surgery and minimally invasive skin cancer procedures.
• Treats patients at the Ella Lemelbaum Institute for Immuno-Oncology.
• Researches perioperative treatments for stage III melanoma and breast lesion excision.
• Works at Sheba Medical Center, ranked 7th worldwide by Newsweek in 2026.

Dr. Mehmet Salih Iyikesici is a medical oncologist. His work focuses on metabolically supported chemotherapy (MSCT), ketogenic diet–supported cancer care, hyperthermia, hyperbaric oxygen therapy, and insulin potentiation therapy. He emphasizes care for breast, pancreatic, and gastric cancers.

He is a Medical Oncology Specialist at Neolife Medical Center (2026–present). He previously served at Private Bahçelievler Medical Park (2013–2026), Medicana Beylikdüzü (2010–2013), Silivri Anadolu (2009–2010), Diyarbakır Training and Research (2008–2009), and Bursa Çekirge State (2006–2008). Earlier, he worked as an Internal Medicine Specialist (1997–2003). He was an Assistant Professor at Altınbaş University (2014–2026).

Training: Medical Oncology subspecialty, Marmara University (2003–2006). Internal Medicine, Istanbul Haydarpaşa Numune (1992–1996). Medicine, Uludağ University (1985–1990). Member, Medical Oncology Association (since 2004). His recent research (2019–2020) covers gastric, breast, pancreatic, and lung cancers. Topics include long‑term survival in metastatic pancreatic cancer and feasibility in metastatic non‑small cell lung cancer (NSCLC).

Dr. David Kuczer is a radiation oncologist at Amethyst Radiotherapy in Vienna. He specializes in precise cancer treatment for tumors of the prostate, breast, and brain. Dr. Kuczer presents every patient case to an interdisciplinary tumor board. This ensures each person receives a validated treatment plan from a team of experts.

• Uses the Elekta Versa HD linear accelerator for precise tumor targeting.
• Treats complex conditions including glioblastoma, lung cancer, and meningioma.
• Coordinates care within a clinic ranked among Newsweek's World's Best Hospitals 2026.
• Provides IMRT, VMAT, and stereotactic radiosurgery for high-accuracy radiation.

Professor Doctor Sefik Igdem specializes in radiation oncology, with advanced expertise in conformal treatments and Truebeam Stx Technology.

• Over 30 years of experience in radiation oncology
• Specializes in head and neck cancers and prostate cancer
• Uses cutting-edge technologies like Halcyons for precise treatment
• Professor at T.R Demiroğlu Bilim University

Dr. Bianchini has led over 100 clinical trials for breast cancer and heads the Breast Cancer Group at San Raffaele Hospital in Milan.

• 21 years specializing in breast cancer treatment
• Head of clinical translational and immunotherapy research
• Published 45+ papers on breast cancer
• Co-inventor of a patent for personalized drug combinations
• Trained at MD Anderson Cancer Center in the US

Dr. Yuri Goldes is the Deputy Director of General Surgery at Sheba Medical Center. He pioneered some of Israel’s first robotic resections for stomach and pancreatic cancers. Forbes Israel named him among the nation’s best gastrointestinal surgeons. In 2019, he received the Best Doctor of the Year award from the Israeli Ministry of Health.

• Specializes in robotic and laparoscopic surgery for pancreatic, gastric, and esophageal cancers.
• Performs minimally invasive Whipple procedures, one of the most complex abdominal operations.
• Treats benign conditions including diaphragmatic hernia, achalasia, GERD, and gallbladder disease.
• Works at Sheba Medical Center, ranked among the Top 10 hospitals worldwide by Newsweek.

Professor Xiao Yueyong is Chief Physician in the Department of Radiological Diagnosis at the Chinese PLA General Hospital. He is a leading expert in minimally invasive interventional oncology. He serves as the inaugural President of WATA (2025–). He is President of the International (2020–) and Asian (2012–) Societies of Cryotherapy. He is also Deputy Head of the NHC Expert Group on tumour ablation regulations (2009–).

He has performed over 100,000 CT/MRI‑guided minimally invasive procedures. His work covers chemical ablation, RFA, MWA, cryoablation, and NanoKnife (IRE). He introduced and advanced NanoKnife ablation in China. He led the first national standards for tumour cryoablation and NanoKnife.

Honors include the National Special Contribution Award (Lifetime Honorary). He received First Prize from the Chinese Medicine Education Association (2021). He received two Second Prizes for Military Medical Achievements (2016, 2018) and two Second Prizes from the China Anti‑Cancer Association (2019, 2022). He was named Asian Ablation Master. His research record includes 13 Chinese patents. He is the principal investigator for four NSFC projects and one MOST subject. He has published over 200 papers, with over 110 as first or corresponding author and over 40 in SCI journals. He has led over 10 ablation guidelines or consensus statements.

Dr. Sinan Karaaslan specializes in breast cancer treatment using chemotherapy, hormone therapy, targeted therapy, and immunotherapy at Anadolu Medical Center.

• 29 years of experience in medical oncology
• Member of the Turkish Medical Oncology Society
• Trained at Istanbul University's Cerrahpaşa Medical School
• Works with a multidisciplinary team at Anadolu's Breast Cancer Center

Dr. Keskin founded and heads the Oncology Center at Memorial Şişli Hospital, using NGS analysis of 600+ genes to personalize breast cancer therapy.

• 25 years of experience in medical oncology
• Ranked 1st in Turkey's Medical Oncology Proficiency Exam
• Specializes in chemotherapy, targeted therapy, and immunotherapy
• Member of ASCO and ESMO
• Published 42 articles in international journals

Assoc. Prof. Mustafa Solak has performed over 1,100 treatments, specializing in breast cancer at Hisar Hospital Intercontinental.

• 20 years of experience in clinical oncology
• Fellowship-trained at Hacettepe University Cancer Institute
• Worked at University of Texas MD Anderson Cancer Center
• Specializes in breast, ovarian, and gastrointestinal cancers